Johnson & Johnson Opens Vaccines Launch Facility In The Netherlands

The healthcare leader's new facility in Leiden, the Netherlands will support global health and the widespread rollout of novel vaccines.

Janssen Pharmaceutical Companies of Johnson & Johnson recently opened its state-of-the-art vaccines launch facility in Leiden, the Netherlands. The new facility represents a significant investment by the company in novel vaccines development, global health and security, and pandemic preparedness efforts. In addition, the facility features innovative technological and manufacturing platforms to support the large-scale production of vaccines for clinical trials and global launch.

The Netherlands
(Source: Johnson & Johnson)

Janssen’s launch facility is the latest example of the company’s leadership in pharmaceutical R&D in the Netherlands. The company will utilize a number of cutting-edge research and development (R&D) platforms at the vaccines launch facility, including Janssen’s proprietary AdVac® viral vector vaccines technology and the company’s PER.C6® manufacturing platform.

“This new center represents a significant commitment by Johnson & Johnson in our mission to change the trajectory of human health,” said Johan Van Hoof, M.D., Global Therapeutic Area Head IDV, Vaccines, Janssen Pharmaceuticals R&D and Managing Director, Janssen Vaccines & Prevention B.V. “By investing locally, we hope to protect globally by ensuring that innovative and effective vaccines become available to the people that need them wherever they may live.”

The Netherlands’ world-class research institutes, supportive R&D tax credits and strategic partnerships between science, industry and government, make it a renowned hub for R&D. Furthermore, Holland is home to R&D operations of major companies like Philips, IBM and MSD. Janssen will utilize Holland’s unmatched technology infrastructure, multilingual workforce and innovative ecosystem to improve global health and create new vaccines.

Biotech, Daily News, Economic Development, Europe, Featured, Industries, Industry Clusters/Hubs, International, R&D/Incubators, Site Selection Factors

clinical trials, corporate expansion, global health, Holland, Johnson & Johnson, Leiden, Netherlands, pandemic, pharmaceutical R&D, vaccines development

Sponsored Content
Featured Location

Location Spotlight: Ohio Electric Cooperatives

Ohio consistently ranks as one of the top U.S. destinations for new corporate facilities, meaning prime sites are quickly snapped up. Economic development officials and private developers are working cooperatively to ensure the pipeline of immediately-developable sites stays full with diverse location opportunities.

Featured Video

Webinars, Podcasts & Videos

supply chain

Listen Now – Supply Chain Gateway: Virginia

From the Port of Virginia to the Hampton Roads Bridge-Tunnel expansion and an eye on air cargo facilities growth, Virginia connects business to markets, domestic and global.

Camp Hall – A Next Generation Commerce Park in South Carolina

Camp Hall is a first-of-its-kind, master-planned industrial work space located in Charleston, S.C. As a convergence of people, place and programming, Camp Hall delivers thoughtful infrastructure and logistical features that empower people — and business — to thrive.

Hear from leaders at the Destination Medical Center and Mayo Clinic Business Development in Rochester about why they feel Minnesota is filled with opportunities for founders and why investors should consider the power of startups in Minnesota.

Business Benefits In Minnesota, a Mayo Clinic Business Development and Destination Medical Center Perspective

Hear from leaders at the Destination Medical Center and Mayo Clinic Business Development in Rochester about why they feel Minnesota is filled with opportunities for founders and why investors should consider the power of startups in Minnesota.

Share to...